Peggy Y. Ho

Peggy Y. Ho is an accomplished professional in the field of strategic pricing and market access, currently serving as Associate Director at Gilead Sciences since July 2025. Prior to this role, Peggy held the position of Associate Director at Red Nucleus from January 2023 to July 2025, where responsibilities included developing market access strategies and commercialization recommendations across diverse global markets. Peggy's extensive experience includes significant roles at Jupiter Life Science Consulting, ZetaGen Therapeutics, and QB3, showcasing expertise in pricing, market access, and product development. Peggy holds a Master's degree in Translational Medicine from the University of California, Berkeley, and a Bachelor of Science in Microbiology, Immunology, and Molecular Genetics from UCLA, further enhancing a strong academic foundation.